Kantrex Side Effects
Generic name: kanamycin
Note: This document contains side effect information about kanamycin. Some of the dosage forms listed on this page may not apply to the brand name Kantrex.
Applies to kanamycin: compounding powder, injectable solution, oral capsule
Nervous system side effects have included neuromuscular blockade, ototoxicity resulting in loss of vestibular function secondary to hair cell damage, and irreversible or partially reversible bilateral hearing loss. Nystagmus, vertigo, nausea, vomiting, and acute Meniere's syndrome are signs of vestibular dysfunction. Cochlear damage may be asymptomatic and may initially manifest as minor changes in audiometric test results at higher frequencies. Aminoglycosides have been associated with acute muscular paralysis, apnea, peripheral neuropathy and encephalopathy (numbness, paresthesia, muscle twitching, seizures), and myasthenia gravis-like syndrome. Neurotoxicity may occur after intrapleural, intraperitoneal, or parenteral administration. Patients with renal impairment may be at a higher risk.[Ref]
Renal side effects have included nephrotoxicity, albuminuria, presence of red and white cells and granular casts, azotemia, oliguria, and increased serum creatinine and BUN.[Ref]
Local reactions have included pain at the injection site after intramuscular injection.[Ref]
Metabolic side effects associated with prolonged kanamycin (the active ingredient contained in Kantrex) treatment have included malabsorption syndrome manifested as increased fecal fat, decreased serum carotene, and decreased xylose absorption.[Ref]
1. "Product Information. Kanamycin (kanamycin)." Raway Pharmacal Inc, Accord, NY.
2. Peloquin CA, Berning SE, Nitta AT, et al. "Aminoglycoside Toxicity: Daily versus Thrice-Weekly Dosing for Treatment of Mycobacterial Diseases." Clin Infect Dis 38 (2004): 1538-44
Medically reviewed by Drugs.com. Last updated on Nov 9, 2020.
More about Kantrex (kanamycin)
Related treatment guides
Some side effects may not be reported. You may report them to the FDA.